Extender las pruebas de diagnóstico precoz del VIH y ofrecer fármacos antirretrovirales a todos los seropositivos es la manera más eficaz de contener la epidemia del sida, y a medio plazo tambin la más barata, según ha demostrado Julio Montaner, ex presidente de la Sociedad Internacional del Sida, en una serie de estudios que ha […]
Extender la detección precoz y la terapia reduce los contagios de VIH Read More »
New cases of HIV among those who use drugs by injection continue to decline in B.C., according to a report by the provincial health officer. A major factor in the decline has been the expansion of Highly Active Anti-retroviral Therapy (HAART) and harm reduction programs, says the report. Introduced in 1997, HAART is a combination
New HIV cases drop among injection drug users in BC Read More »
A new report says there are fewer new cases of HIV among injection drug users in B.C., and health officials are crediting the province’s harm reduction programs. The report by the provincial health officer says the number of new HIV infections has remained stable nationally, but in B.C. in 2009 there were 64 new cases
Health officials credit harm reduction for decline in B.C. HIV cases Read More »
B.C.’s top doctor is pushing to keep harm reduction and anti-retroviral therapy as key health strategies after a new report showed rates of HIV infection among those who inject drugs continues to drop. Provincial health officer Dr. Perry Kendall released the report noting several reasons why intravenous drug users aren’t catching HIV or hepatitis C
HIV dropping among IV drug users due to harm reduction, says B.C.’s health officer Read More »
Harm reduction measures and anti-retroviral therapy are cutting down B.C.’s HIV infection rates among injection drug users, says a new report released Thursday by the Health Ministry. Provincial health officer Dr. Perry Kendall released a report revealing several factors associated with the drop in intravenous drug users catching HIV or hepatitis C. Among the factors
HIV rates among injection drug users continue to drop Read More »
HIV-AIDS rates among injection drug users in B.C. have dropped by 50 per cent, according to B.C. foremost expert on the issue. Dr. Julio Montaner, of the B.C. Centre for Excellence in HIV/AIDS, said that in 1996 there were approximately 800 new HIV diagnoses in B.C. Currently, there are approximately 350 HIV diagnoses per year.
HIV/AIDS rates way down in B.C. Read More »
The Chinese government has announced it will use a treatment strategy developed in B.C. to combat the spread of HIV and AIDS in China. The country has 740,000 people infected with HIV and a further 110,000 with AIDS. The “treatment as prevention” model being adopted by China was pioneered by the BC Centre for Excellence
B.C.-developed strategy to combat HIV spread in China Read More »
China will follow the example set by an agency in B.C. to set its national HIV/AIDS policy. The BC Centre for Excellence in HIV/AIDS’ calls for widespread HIV testing and treatment for everyone who is medically-eligible. In a study published last summer in the Lancet the centre observed that highly active anti-retroviral therapy (HAART) –
China chooses AIDS control model from B.C. Read More »
Deep inside the maze of offices in the West End’s St. Paul’s Hospital, Julio Montaner has been leading a global revolution to stop the spread of HIV/AIDS. For the past four decades, the Argentinian-born doctor has been at the forefront of finding treatments for the infected and reaching others before they suffer the same fate.
A Nanaimo clinic wants to get the public talking about a new approach to preventing the spread of HIV in the hopes that it may soon be brought to the Harbour City. The AVI Health Centre is bringing leading HIV/AIDS expert Dr. Julio Montaner to Nanaimo Monday (Jan. 24) to talk about the new approach
HIV/AIDS clinic hopes to expand services Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
